4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-24-129677
Chief Executive Officer acquired 12,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2024-11-21 | Option exercise | +12,900 | $1.55 | $19,995 | 343,635 | D |
| Derivatives | |||||||
| Tak Paul Peter Chief Executive Officer | 2024-11-21 | Option exercise · Stock Option (Right to Buy) | −12,900 | 1,763,968 | D | ||
Loading xslF345X05/ownership.xml…